GyeongHwan Lee - BH Co CEO Director
090460 Stock | KRW 17,560 250.00 1.40% |
Insider
GyeongHwan Lee is CEO Director of BH Co
Age | 63 |
Phone | (82) 32 514 8677 |
Web | www.bhe.co.kr |
BH Co Management Efficiency
The company has return on total asset (ROA) of 0.0285 % which means that it generated a profit of $0.0285 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 36.4395 %, meaning that it generated $36.4395 on every $100 dollars invested by stockholders. BH Co's management efficiency ratios could be used to measure how well BH Co manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Hyeong Park | SOOSAN INT Co | 41 | |
DongHan Kim | Dongsin Engineering Constructio | 70 | |
ChulSu Lee | Finetechnix CoLtd | N/A | |
TaeHwan Kim | Finetechnix CoLtd | 66 | |
Hwan Sung | AptaBio Therapeutics | N/A | |
Chan Park | SOOSAN INT Co | 55 | |
Gyeong Yoon | SOOSAN INT Co | 53 | |
EuiSik Kwon | Total Soft Bank | 77 | |
GeunHan Kim | Dongsin Engineering Constructio | 75 | |
Bong Choi | DeviceENGCOLtd | N/A | |
JungHyuk Choi | Finetechnix CoLtd | 68 | |
Gi Gil | SOOSAN INT Co | 63 | |
CheolSun Kim | Finetechnix CoLtd | N/A | |
Eun Jung | SOOSAN INT Co | 38 | |
Beom Kim | SOOSAN INT Co | 42 | |
Jin Soo | AptaBio Therapeutics | N/A | |
InYong Yoon | Finetechnix CoLtd | 65 | |
Yong Lee | SOOSAN INT Co | 52 |
Management Performance
Return On Equity | 36.44 | |||
Return On Asset | 0.0285 |
BH Co Leadership Team
Elected by the shareholders, the BH Co's board of directors comprises two types of representatives: BH Co inside directors who are chosen from within the company, and outside directors, selected externally and held independent of 090460. The board's role is to monitor BH Co's management team and ensure that shareholders' interests are well served. BH Co's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BH Co's outside directors are responsible for providing unbiased perspectives on the board's policies.
ChangHo Jeong, VP | ||
WooTae Kim, MD Manufacture | ||
YoungSik Choi, MD Director | ||
IIYong Jung, MD Funds | ||
GyeongHwan Lee, CEO Director |
090460 Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BH Co a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 36.44 | |||
Return On Asset | 0.0285 | |||
Profit Margin | 0.04 % | |||
Operating Margin | 0.03 % | |||
Current Valuation | 692.95 B | |||
Shares Outstanding | 29.41 M | |||
Shares Owned By Insiders | 21.66 % | |||
Shares Owned By Institutions | 8.67 % | |||
Price To Earning | 136.00 X | |||
Price To Sales | 0.87 X |
Pair Trading with BH Co
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BH Co position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BH Co will appreciate offsetting losses from the drop in the long position's value.Moving together with 090460 Stock
Moving against 090460 Stock
The ability to find closely correlated positions to BH Co could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BH Co when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BH Co - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BH Co to buy it.
The correlation of BH Co is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BH Co moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BH Co moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BH Co can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in 090460 Stock
BH Co financial ratios help investors to determine whether 090460 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 090460 with respect to the benefits of owning BH Co security.